Literature DB >> 33390853

Potential roles of mediator Complex Subunit 13 in Cardiac Diseases.

Wenqian Zhou1,2, He Cai1, Jia Li2,3, He Xu4, Xiang Wang1,2, Hongbo Men1,2, Yang Zheng1, Lu Cai2,5.   

Abstract

Mediator complex subunit 13 (MED13, previously known as THRAP1 and TRAP240) is a subunit of the cyclin-dependent kinase 8 (CDK8) kinase module in the eukaryotic mediator complex. MED13 has been known to play critical roles in cell cycle, development, and growth. The purpose of this review is to comprehensively discuss its newly identified potential roles in myocardial energy metabolism and non-metabolic cardiovascular diseases. Evidence indicates that cardiac MED13 mainly participates in the regulation of nuclear receptor signaling, which drives the transcription of genes involved in modulating cardiac and systemic energy homeostasis. MED13 is also associated with several pathological conditions, such as metabolic syndrome and thyroid disease-associated heart failure. Therefore, MED13 constitutes a potential therapeutic target for the regulation of metabolic disorders and other cardiovascular diseases. © The author(s).

Entities:  

Keywords:  MED13; cardiovascular diseases; energy metabolism

Mesh:

Substances:

Year:  2021        PMID: 33390853      PMCID: PMC7757031          DOI: 10.7150/ijbs.52290

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


  107 in total

Review 1.  Adipose Organ Development and Remodeling.

Authors:  Saverio Cinti
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  NURR1 activation in skeletal muscle controls systemic energy homeostasis.

Authors:  Leonela Amoasii; Efrain Sanchez-Ortiz; Teppei Fujikawa; Joel K Elmquist; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

3.  Zebrafish Trap230/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development.

Authors:  Marlene J Rau; Sabine Fischer; Carl J Neumann
Journal:  Dev Biol       Date:  2006-04-21       Impact factor: 3.582

Review 4.  Control of Muscle Metabolism by the Mediator Complex.

Authors:  Leonela Amoasii; Eric N Olson; Rhonda Bassel-Duby
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

Review 5.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

6.  Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*.

Authors:  Michele Carrer; Ning Liu; Chad E Grueter; Andrew H Williams; Madlyn I Frisard; Matthew W Hulver; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

7.  Drosophila homologues of the transcriptional coactivation complex subunits TRAP240 and TRAP230 are required for identical processes in eye-antennal disc development.

Authors:  J Treisman
Journal:  Development       Date:  2001-02       Impact factor: 6.868

Review 8.  Inter-organ communication: a gatekeeper for metabolic health.

Authors:  Judit Castillo-Armengol; Lluis Fajas; Isabel C Lopez-Mejia
Journal:  EMBO Rep       Date:  2019-08-19       Impact factor: 8.807

Review 9.  Regulatory functions of the Mediator kinases CDK8 and CDK19.

Authors:  Charli B Fant; Dylan J Taatjes
Journal:  Transcription       Date:  2018-12-26

10.  A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism.

Authors:  Leonela Amoasii; William Holland; Efrain Sanchez-Ortiz; Kedryn K Baskin; Mackenzie Pearson; Shawn C Burgess; Benjamin R Nelson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Genes Dev       Date:  2016-02-15       Impact factor: 11.361

View more
  1 in total

Review 1.  Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.

Authors:  Vilbert Sikorski; Antti Vento; Esko Kankuri
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-20       Impact factor: 10.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.